• Systematic Review Of Pivotal Studies Of Oncology Drugs Authorized In Italy Since 2013- Correlation Between Studies’ Main Characteristics And Time To Patient

    Oct 1, 2017, 00:00

  • Conditions And Contextual Factors That Influence The Utility And Application Of Patient Preference Studies- A Study Combining Literature And Focus Groups

    Oct 1, 2017, 00:00

  • Retrospective Analysis of The Ceesp Efficiency Opinions and Eligibility Criteria for Assessment Since Its Creation

    Oct 1, 2017, 00:00

  • An Analysis Of HTA And Reimbursement Processes In Eunethta Partner Countries- Implications For Implementing HTA Cooperation

    Oct 1, 2017, 00:00

  • The Burden of Genital Warts In Latin America- A Review of the Evidence

    Oct 1, 2017, 00:00

  • Safety And Efficacy of Osimertinib As A Therapy In Patients With Egfr T790M Positive Non Small Cell Lung Cancer Patients- A Systematic Review

    Oct 1, 2017, 00:00

  • Quality of Life in Patients with Kidney Transplantation in Czech Republic

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece

    Oct 1, 2017, 00:00

  • The First EQ-5D-5L Value Set In Central And Eastern Europe

    Oct 1, 2017, 00:00

  • Burnout Syndrome among Healthcare Professionals working in Gondar University Hospital, Northwest Ethiopia- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Economic Evaluation of Trifluridine and Tipiracil Hydrochloride in The Treatment of Metastatic Colorectal Cancer in Greece

    Oct 1, 2017, 00:00

  • Real-World Health Care Resource Utilization and Related Costs Among Patients Who Received At Least Two Lines of Treatment for Advanced Nsclc in England, The Netherlands, and Sweden

    Oct 1, 2017, 00:00

  • Estimating The Prevalece of Depression In Patients With Rheumatoid Arthritis In Korea Using National Health Insurance Claims Data

    Oct 1, 2017, 00:00

  • Management And Cost Analysis Of Cancer Patients Treated With G-CSF- A Cohort Study Based On The French National Healthcare Insurance Database (Echantillon Généraliste Des Bénéficiaires)

    Oct 1, 2017, 00:00

  • 3-Steps Stragety for Patients Early Access to an Unauthorized Medication / Device Project Design (Based on 23 Projects Analyses Including EAP, CUP, NPP, IND, ATU)

    Oct 1, 2017, 00:00

  • Managed Entry Agreements (MEA)- Analysis Of The Current Situation In Middle East And North Africa

    Oct 1, 2017, 00:00

  • Health Care Resource Use (HCRU) Due To Bleeding Related Episodes (BRE) In Patients With Immune Thrombocytopenic Purpura (ITP) Receiving Eltrombopag (EPAG), Romiplostim (ROMI), Or Rituximab (RITUX)- Real World Evidence (RWE) From 27 US Insti ...

    Oct 1, 2017, 00:00

  • Healthcare Costs Of Patients With Acute And Chronic Graft-Versus-Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation In Belgium- A Retrospective Data Collection And Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Alemtuzumab In The Treatment of Relapsing Forms of Multiple Sclerosis In The United States and Societal Spillover Effects

    Oct 1, 2017, 00:00

  • Idiopathic Pulmonary Fibrosis- A Cost Of Illness Analysis In Greece

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Daratumumab in Heavily Pre-Treated Multiple Myeloma Patients for The Italian Healthcare System

    Oct 1, 2017, 00:00

  • Cost Analysis of Pre-Dialysis- A Model in the Brazilian context

    Oct 1, 2017, 00:00

  • Estimating the Effect and Economic Impact of Absenteeism, Presenteeism, and Work Environment–Related Problems on Reductions in Productivity from a Managerial Perspective

    Sep 1, 2017, 00:00

  • Making Real-World Evidence More Useful for Decision Making

    Sep 1, 2017, 00:00

  • Evaluation of a Stratified National Breast Screening Program in the United Kingdom- An Early Model-Based Cost-Effectiveness Analysis

    Sep 1, 2017, 00:00

  • Market Exclusivity Time for Top Selling Originator Drugs in Canada- A Cohort Study

    Sep 1, 2017, 00:00

  • Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness- Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making

    Sep 1, 2017, 00:00

  • ERRATUM

    Sep 1, 2017, 00:00

  • Editorial Board

    Sep 1, 2017, 00:00

  • A Systematic Review of the Economic Evidence for Home Support Interventions in Dementia

    Sep 1, 2017, 00:00

  • Cost Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal

    Sep 1, 2017, 00:00

  • Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0

    Sep 1, 2017, 00:00

  • Economic Burden of Illness among Persons with Hemophilia B from HUGS Vb- Examining the Association of Severity and Treatment Regimens with Costs and Annual Bleed Rates

    Sep 1, 2017, 00:00

  • An Experience-Based Value Set for the EQ-5D-5L in Germany

    Sep 1, 2017, 00:00

  • Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists

    Sep 1, 2017, 00:00

  • Copyright/Subscription

    Sep 1, 2017, 00:00

  • Cost-Utility of Partially Implantable Active Middle Ear Implants for Sensorineural Hearing Loss- A Decision Analysis

    Sep 1, 2017, 00:00

  • Table of Contents

    Sep 1, 2017, 00:00

  • Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis

    Sep 1, 2017, 00:00

  • A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data

    Sep 1, 2017, 00:00

  • Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular Degeneration

    Sep 1, 2017, 00:00

  • The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria

    Sep 1, 2017, 00:00

  • Discordance in Utility Measurement in Persons with Neurological Conditions- A Comparison of the SF-6D and the HUI3

    Sep 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure

    Sep 1, 2017, 00:00

  • Atrial Fibrillation as an Ischemic Stroke Clinical and Economic Burden Modifier- A 15-Year Nationwide Study

    Sep 1, 2017, 00:00

  • Determination of Cost-Effectiveness Threshold for Health Care Interventions in Malaysia

    Sep 1, 2017, 00:00

  • A Systematic Review of the Techniques Used to Value Temporary Health States

    Sep 1, 2017, 00:00

  • Economic Evaluations of Pathology Tests, 2010-2015- A Scoping Review

    Sep 1, 2017, 00:00

  • Value-Based Payments and Incentives to Improve Care- A Case Study of Patients with Type 2 Diabetes in Medicare Advantage

    Sep 1, 2017, 00:00

  • Do Robotic Surgical Systems Improve Profit Margins? A Cross-Sectional Analysis of California Hospitals

    Sep 1, 2017, 00:00

  • Scale Linking to Enable Patient-Reported Outcome Performance Measures Assessed with Different Patient-Reported Outcome Measures

    Sep 1, 2017, 00:00

  • Towards Integrated Health Technology Assessment for Improving Decision Making in Selected Countries

    Sep 1, 2017, 00:00

  • Cost-Utility of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1 Infection

    Sep 1, 2017, 00:00

  • Estimating Health-State Utility Values in Kidney Transplant Recipients and Waiting-List Patients Using the EQ-5D-5L

    Jul 1, 2017, 00:00

  • Dealing with Uncertainty and Accounting for Social Value Judgments in Assessments of Orphan Drugs- Evidence from Four European Countries

    Jul 1, 2017, 00:00

  • Less Is More- Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values

    Jul 1, 2017, 00:00

  • Copyright/Subscription

    Jul 1, 2017, 00:00

  • The HIQA’s Health Technology Assessment of Breast Screening- Highlighting Some of the Challenges Posed by Evaluations of Screening Programs

    Jul 1, 2017, 00:00

  • Aripiprazole Lauroxil Compared with Paliperidone Palmitate in Patients with Schizophrenia- An Indirect Treatment Comparison

    Jul 1, 2017, 00:00

  • Valid Outcome Measures in Care for Older People- Comparing the ASCOT and the ICECAP-O

    Jul 1, 2017, 00:00

  • Cost-Effectiveness Analysis of an Automated Medication System Implemented in a Danish Hospital Setting

    Jul 1, 2017, 00:00

  • Pharmaceutical Pricing in Germany- How Is Value Determined within the Scope of AMNOG?

    Jul 1, 2017, 00:00

  • Remembering a Giant in Economics- Kenneth J. Arrow (1922–2017)

    Jul 1, 2017, 00:00

  • A Review of Empirical Analyses of Disinvestment Initiatives

    Jul 1, 2017, 00:00

  • Impact of Survey Administration Mode on the Results of a Health-Related Discrete Choice Experiment- Online and Paper Comparison

    Jul 1, 2017, 00:00

  • Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Trials

    Jul 1, 2017, 00:00

  • The Prime Diabetes Model- Novel Methods for Estimating Long-Term Clinical and Cost Outcomes in Type 1 Diabetes Mellitus

    Jul 1, 2017, 00:00

  • Testing the External Validity of a Discrete Choice Experiment Method- An Application to Latent Tuberculosis Infection Treatment

    Jul 1, 2017, 00:00

  • Would a Large tPA Trial for Those 4.5 to 6.0 Hours from Stroke Onset Be Good Value for Information?

    Jul 1, 2017, 00:00

  • Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials- Empirical Evidence for the ASCO Value Framework

    Jul 1, 2017, 00:00

  • Table of Contents

    Jul 1, 2017, 00:00

  • What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews

    Jul 1, 2017, 00:00

  • Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials- An ISPOR COA Emerging Good Practices Task Force Report

    Jul 1, 2017, 00:00

  • In this Issue

    Jul 1, 2017, 00:00

  • Public Preferences for Lung Cancer Screening Policies

    Jul 1, 2017, 00:00

  • How to Compare the Length of Stay of Two Samples of Inpatients? A Simulation Study to Compare Type I and Type II Errors of 12 Statistical Tests

    Jul 1, 2017, 00:00

  • Ethics of Informed Consent for Pragmatic Trials with New Interventions

    Jul 1, 2017, 00:00

  • Economic Consequences and Potentially Preventable Costs Related to Osteoporosis in the Netherlands

    Jun 1, 2017, 00:00

  • Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION)- A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population

    Jun 1, 2017, 00:00

  • Value for Money in H1N1 Influenza- A Systematic Review of the Cost-Effectiveness of Pandemic Interventions

    Jun 1, 2017, 00:00

  • Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations

    Jun 1, 2017, 00:00

  • Manual Compression versus Vascular Closing Device for Closing Access Puncture Site in Femoral Left-Heart Catheterization and Percutaneous Coronary Interventions- A Retrospective Cross-Sectional Comparison of Costs and Effects in Inpatient C ...

    Jun 1, 2017, 00:00

  • Mind the Gap- Hospitalizations from Multiple Sources in a Longitudinal Study

    Jun 1, 2017, 00:00

  • Economic Impacts of the Generic Drug User Fee Act Fee Structure

    Jun 1, 2017, 00:00

  • Challenges of Developing an Observable Parent-Reported Measure- A Qualitative Study of Functional Impact of ADHD in Children

    Jun 1, 2017, 00:00

  • Ulcerative Colitis Treatment Patterns and Cost of Care

    Jun 1, 2017, 00:00

  • The Role of Patient-Reported Outcome Measures in Value-Based Payment Reform

    Jun 1, 2017, 00:00

  • Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention

    Jun 1, 2017, 00:00

  • The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs

    Jun 1, 2017, 00:00

  • Editorial Board

    Jun 1, 2017, 00:00

  • The Type and Impact of Evidence Review Group Exploratory Analyses in the NICE Single Technology Appraisal Process

    Jun 1, 2017, 00:00

  • In this Issue

    Jun 1, 2017, 00:00

  • Eliciting Preferences for Clinical Follow-Up in Patients with Head and Neck Cancer Using Best-Worst Scaling

    Jun 1, 2017, 00:00

  • Message from Co-Editors

    May 1, 2017, 00:00

  • Editorial Board

    May 1, 2017, 00:00

  • 22nd International Abstracts Book

    May 1, 2017, 00:00

  • ToC

    May 1, 2017, 00:00

  • Copyright/Subscription

    May 1, 2017, 00:00

  • 22ND International Abstracts-FDS

    May 1, 2017, 00:00

  • Association of Preference-Based Health-Related Quality of Life with Weight Loss in Obese Adults

    Apr 1, 2017, 00:00

  • Cost-Effectiveness Thresholds in Global Health- Taking a Multisectoral Perspective

    Apr 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Systemic Therapies in Advanced Pancreatic Cancer in the Canadian Health Care System

    Apr 1, 2017, 00:00

  • Eliciting Preferences for Information Provision in Newborn Bloodspot Screening Programs

    Apr 1, 2017, 00:00

  • Be Careful What You Ask For- Effects of Benefit Descriptions on Diabetes Patients’ Benefit-Risk Tradeoff Preferences

    Apr 1, 2017, 00:00

  • Cost-Effectiveness of TNF-Blocker Injection Spacing for Patients with Established Rheumatoid Arthritis in Remission- An Economic Evaluation from the Spacing of TNF-Blocker Injections in Rheumatoid Arthritis Trial

    Apr 1, 2017, 00:00

  • A Practical ANOVA Approach for Uncertainty Analysis in Population-Based Disease Microsimulation Models

    Apr 1, 2017, 00:00

  • In this Issue

    Apr 1, 2017, 00:00

  • Evaluation of Noncompletion Bias and Long-Term Adherence in a 10-Year Patient-Reported Outcome Monitoring Program in Clinical Routine

    Apr 1, 2017, 00:00

  • Table of Contents

    Apr 1, 2017, 00:00

  • Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy- EQ-5D-3L and NEWQOL-6D

    Apr 1, 2017, 00:00

  • A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer

    Apr 1, 2017, 00:00

  • Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years

    Apr 1, 2017, 00:00

  • A Novel Patient-Derived Conceptual Model of the Impact of Celiac Disease in Adults- Implications for Patient-Reported Outcome and Health-Related Quality-of-Life Instrument Development

    Apr 1, 2017, 00:00

  • Impact of a University-Based Outpatient Telemedicine Program on Time Savings, Travel Costs, and Environmental Pollutants

    Apr 1, 2017, 00:00

  • The PMA Scale- A Measure of Physicians’ Motivation to Adopt Medical Devices

    Apr 1, 2017, 00:00

  • Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials- Foundational Qualitative Research

    Apr 1, 2017, 00:00

  • Policies for Use of Real-World Data in Health Technology Assessment (HTA)- A Comparative Study of Six HTA Agencies

    Apr 1, 2017, 00:00

  • Editorial Board

    Apr 1, 2017, 00:00

  • Systematic Review of Health Economic Impact Evaluations of Risk Prediction Models- Stop Developing, Start Evaluating

    Apr 1, 2017, 00:00

  • Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores

    Apr 1, 2017, 00:00

  • The Diagnosis of Urinary Tract Infection in Young Children (DUTY) Study Clinical Rule- Economic Evaluation

    Apr 1, 2017, 00:00

  • Copyright/Subscription

    Apr 1, 2017, 00:00

  • Economic Burden of Attention-Deficit/Hyperactivity Disorder among Pediatric Patients in the United States

    Apr 1, 2017, 00:00

  • Estimating an EQ-5D-5L Value Set for China

    Apr 1, 2017, 00:00

  • Balancing the Optimal and the Feasible- A Practical Guide for Setting Up Patient Registries for the Collection of Real-World Data for Health Care Decision Making Based on Dutch Experiences

    Apr 1, 2017, 00:00

  • A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer

    Apr 1, 2017, 00:00

  • Accounting for Cured Patients in Cost-Effectiveness Analysis

    Apr 1, 2017, 00:00

  • Determining Criteria and Weights for Prioritizing Health Technologies Based on the Preferences of the General Population- A New Zealand Pilot Study

    Apr 1, 2017, 00:00

  • Limited Effectiveness of Diabetes Risk Assessment Tools in Seniors’ Facility Residents

    Mar 1, 2017, 00:00

  • Time to Review the Role of Surrogate End Points in Health Policy- State of the Art and the Way Forward

    Mar 1, 2017, 00:00

  • Patient Preferences for Minimally Invasive and Open Locoregional Treatment for Early-Stage Breast Cancer

    Mar 1, 2017, 00:00

  • Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus- Informing Economic Modeling

    Mar 1, 2017, 00:00

  • Emerging Guidelines for Patient Engagement in Research

    Mar 1, 2017, 00:00

  • Joint Utility Estimators in Substance Use Disorders

    Mar 1, 2017, 00:00

  • Constrained Optimization Methods in Health Services Research—An Introduction- Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force

    Mar 1, 2017, 00:00

  • ERRATUM

    Mar 1, 2017, 00:00

  • External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD)- Report of the Third COPD Modeling Meeting

    Mar 1, 2017, 00:00

  • Editorial Board

    Mar 1, 2017, 00:00

  • Health State Utilities Associated with Glucose Monitoring Devices

    Mar 1, 2017, 00:00

  • Copyright/Subscription

    Mar 1, 2017, 00:00

  • A Cost-Effectiveness Analysis of Reverse Total Shoulder Arthroplasty versus Hemiarthroplasty for the Management of Complex Proximal Humeral Fractures in the Elderly

    Mar 1, 2017, 00:00

  • Table of Contents

    Mar 1, 2017, 00:00

  • Cost Savings from Reduced Hospitalizations with Use of Home Noninvasive Ventilation for COPD

    Mar 1, 2017, 00:00

  • Costs for Childhood and Adolescent Cancer, 90 Days Prediagnosis and 1 Year Postdiagnosis- A Population-Based Study in Ontario, Canada

    Mar 1, 2017, 00:00

  • Psychometric Evaluation of a Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection

    Mar 1, 2017, 00:00

  • Quality Control Process for EQ-5D-5L Valuation Studies

    Mar 1, 2017, 00:00

  • Real-World Data for the Evaluation of Transarterial Radioembolization versus Sorafenib in Hepatocellular Carcinoma- A Cost-Effectiveness Analysis

    Mar 1, 2017, 00:00

  • The Impact of China’s National Essential Medicine Policy and Its Implications for Urban Outpatients- A Multivariate Difference-in-Differences Study

    Mar 1, 2017, 00:00

  • The 3-Year Cost-Effectiveness of a Nurse-Based Case Management versus Usual Care for Elderly Patients with Myocardial Infarction- Results from the KORINNA Follow-Up Study

    Mar 1, 2017, 00:00

  • A Review of Patient-Reported Outcome Labeling in the United States (2011–2015)

    Mar 1, 2017, 00:00

  • Health Technology Assessment (HTA) Case Studies- Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland

    Mar 1, 2017, 00:00

  • Preference Weighting of Health State Values- What Difference Does It Make, and Why?

    Mar 1, 2017, 00:00

  • The Estimation and Inclusion of Presenteeism Costs in Applied Economic Evaluation- A Systematic Review

    Mar 1, 2017, 00:00

  • In this Issue

    Mar 1, 2017, 00:00

  • Treacle and Smallpox- Two Tests for Multicriteria Decision Analysis Models in Health Technology Assessment

    Mar 1, 2017, 00:00

  • An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands

    Mar 1, 2017, 00:00

  • Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan

    Mar 1, 2017, 00:00

  • Advancing High-Quality Value Assessments of Health Care Interventions

    Feb 1, 2017, 00:00

  • Three Sets of Case Studies Suggest Logic and Consistency Challenges with Value Frameworks

    Feb 1, 2017, 00:00

  • Comparing Increments in Utility of Health- An Individual-based Approach

    Feb 1, 2017, 00:00

  • Cost-Effectiveness and Dynamic Efficiency- Does the Solution Lie Within?

    Feb 1, 2017, 00:00

  • The HTA Core Model—10 Years of Developing an International Framework to Share Multidimensional Value Assessment

    Feb 1, 2017, 00:00

  • Value to Whom? The Patient Voice in the Value Discussion

    Feb 1, 2017, 00:00

  • Value Assessment in the Regulatory Context

    Feb 1, 2017, 00:00

  • Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs

    Feb 1, 2017, 00:00

  • Toward a Hedonic Value Framework in Health Care

    Feb 1, 2017, 00:00

  • Concerns Around Budget Impact Thresholds- Not All Drugs Are the Same

    Feb 1, 2017, 00:00

  • The Probabilistic Efficiency Frontier- A Framework for Cost-Effectiveness Analysis in Germany Put into Practice for Hepatitis C Treatment Options

    Feb 1, 2017, 00:00

  • Evaluating Frameworks That Provide Value Measures for Health Care Interventions

    Feb 1, 2017, 00:00

  • Developing a Value Framework- The Need to Reflect the Opportunity Costs of Funding Decisions

    Feb 1, 2017, 00:00

  • Toward a Broader Concept of Value- Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis

    Feb 1, 2017, 00:00

  • The Fiscal Consequences Attributed to Changes in Morbidity and Mortality Linked to Investments in Health Care- A Government Perspective Analytic Framework

    Feb 1, 2017, 00:00

  • Advancing Value Assessment in the United States- A Multistakeholder Perspective

    Feb 1, 2017, 00:00

  • Using Multicriteria Approaches to Assess the Value of Health Care

    Feb 1, 2017, 00:00

  • Value Assessment Frameworks for HTA Agencies- The Organization of Evidence-Informed Deliberative Processes

    Feb 1, 2017, 00:00

  • Table of Contents

    Feb 1, 2017, 00:00

  • Using Cost-Effectiveness Analysis to Address Health Equity Concerns

    Feb 1, 2017, 00:00

  • The Value of Addressing Patient Preferences

    Feb 1, 2017, 00:00

  • Copyright/Subscription

    Feb 1, 2017, 00:00

  • Value Assessment at the Point of Care- Incorporating Patient Values throughout Care Delivery and a Draft Taxonomy of Patient Values

    Feb 1, 2017, 00:00

  • Patient Versus Physician Valuation of Durable Survival Gains- Implications for Value Framework Assessments

    Feb 1, 2017, 00:00

  • The Questionable Economic Case for Value-Based Drug Pricing in Market Health Systems

    Feb 1, 2017, 00:00

  • New ISPOR Recommendations - Mapping Methods for Estimation of Health State Utility

    Jan 1, 2017, 00:00

  • Health State Preference Weights for the Glasgow Outcome Scale Following Traumatic Brain Injury- A Systematic Review and Mapping Study

    Jan 1, 2017, 00:00

  • In This Issue

    Jan 1, 2017, 00:00

  • Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service

    Jan 1, 2017, 00:00

  • Reflections on ISPOR’s Clinician-Reported Outcomes Good Measurement Practice Recommendations

    Jan 1, 2017, 00:00

  • The Influence of Genotype Information on Psychiatrists’ Treatment Recommendations- More Experienced Clinicians Know Better What to Ignore

    Jan 1, 2017, 00:00

  • Economic Evaluations Comparing a Trial of Labor with an Elective Repeat Cesarean Delivery- A Systematic Review

    Jan 1, 2017, 00:00

  • The Challenge of Conditional Reimbursement- Stopping Reimbursement Can Be More Difficult Than Not Starting in the First Place!

    Jan 1, 2017, 00:00

  • Copyright/Subscription

    Jan 1, 2017, 00:00

  • Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures- An ISPOR Good Practices for Outcomes Research Task Force Report

    Jan 1, 2017, 00:00

  • Assessing the Value and Implications of Personalized/Precision Medicine and the “Lessons Learned” for Emerging Technologies- An Introduction

    Jan 1, 2017, 00:00

  • “What Goes Around Comes Around”- Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine

    Jan 1, 2017, 00:00

  • Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice

    Jan 1, 2017, 00:00

  • Decision Making on Medical Innovations in a Changing Health Care Environment- Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies

    Jan 1, 2017, 00:00

  • Budget Impact Analysis of Prolonged Half-Life Recombinant FVIII Therapy for Hemophilia in the United States

    Jan 1, 2017, 00:00

  • Variation in Health Technology Assessment and Reimbursement Processes in Europe

    Jan 1, 2017, 00:00

  • Clinician-Reported Outcome Assessments of Treatment Benefit- Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force

    Jan 1, 2017, 00:00

  • Table of Contents

    Jan 1, 2017, 00:00

  • Estimating Preferences for Complex Health Technologies- Lessons Learned and Implications for Personalized Medicine

    Jan 1, 2017, 00:00

  • Incorporating Budget Impact Analysis in the Implementation of Complex Interventions- A Case of an Integrated Intervention for Multimorbid Patients within the CareWell Study

    Jan 1, 2017, 00:00

  • A Systematic Review of Health Economics Simulation Models of Chronic Obstructive Pulmonary Disease

    Jan 1, 2017, 00:00

  • ERRATUM

    Jan 1, 2017, 00:00

  • Priority to End of Life Treatments? Views of the Public in the Netherlands

    Jan 1, 2017, 00:00

  • New French Coverage with Evidence Development for Innovative Medical Devices- Improvements and Unresolved Issues

    Jan 1, 2017, 00:00

  • Costs and Outcomes of Increasing Access to Bariatric Surgery- Cohort Study and Cost-Effectiveness Analysis Using Electronic Health Records

    Jan 1, 2017, 00:00

  • Note to Editors

    Jan 1, 2017, 00:00

  • Results from a Well-Being Survey in the North West of England- Inequalities in EQ-5D–Derived Quality-Adjusted Life Expectancy Are Mainly Driven by Pain and Mental Health

    Jan 1, 2017, 00:00

  • Evaluation of COPD Treatments- A Multicriteria Decision Analysis of Aclidinium and Tiotropium in the United States

    Jan 1, 2017, 00:00

  • The Burden of Obesity on Diabetes in the United States- Medical Expenditure Panel Survey, 2008 to 2012

    Jan 1, 2017, 00:00

  • Making Choices on the Journey to Universal Health Care Coverage- From Advocacy to Analysis

    Dec 1, 2016, 00:00

  • Reviewer Acknowledgement

    Dec 1, 2016, 00:00

  • EQ-5D Scores for Diabetes-Related Comorbidities

    Dec 1, 2016, 00:00

  • Economic Evaluations of Multicomponent Disease Management Programs with Markov Models- A Systematic Review

    Dec 1, 2016, 00:00

  • From the Co-Editors-In-Chief

    Dec 1, 2016, 00:00

  • Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States

    Dec 1, 2016, 00:00

  • Health Economics as Rhetoric- The Limited Impact of Health Economics on Funding Decisions in Four European Countries

    Dec 1, 2016, 00:00

  • Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants

    Dec 1, 2016, 00:00

  • Translating Pharmacometrics to a Pharmacoeconomic Model of COPD

    Dec 1, 2016, 00:00

  • Instructions for Authors

    Dec 1, 2016, 00:00

  • How to Get Cost-Effectiveness Analysis Right? The Case of Vaccine Economics in Latin America

    Dec 1, 2016, 00:00

  • A Differential Item Functioning Analysis of the EQ-5D in Cancer

    Dec 1, 2016, 00:00

  • The Cost of Costing Treatments Incorrectly- Errors in the Application of Drug Prices in Economic Evaluation Due to Failing to Account for the Distribution of Patient Weight

    Dec 1, 2016, 00:00

  • Table of Contents

    Dec 1, 2016, 00:00

  • Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland

    Dec 1, 2016, 00:00

  • Cancer Care Coordinators to Improve Tamoxifen Persistence in Breast Cancer- How Heterogeneity in Baseline Prognosis Impacts on Cost-Effectiveness

    Dec 1, 2016, 00:00

  • Life Expectancy and Lifetime Health Care Expenditures for Type 1 Diabetes- A Nationwide Longitudinal Cohort of Incident Cases Followed for 14 Years

    Dec 1, 2016, 00:00

  • The International Decision Support Initiative Reference Case for Economic Evaluation- An Aid to Thought

    Dec 1, 2016, 00:00

  • Country-Level Cost-Effectiveness Thresholds- Initial Estimates and the Need for Further Research

    Dec 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Nivolumab Compared with Ipilimumab for the Treatment of BRAF Wild-Type Advanced Melanoma in Australia

    Dec 1, 2016, 00:00

  • Editorial Board

    Dec 1, 2016, 00:00

  • Copyright/Subscription

    Dec 1, 2016, 00:00

  • Update to the Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for Five Health-Related Quality-of-Life Scores

    Dec 1, 2016, 00:00

  • Order of Presentation of Dimensions Does Not Systematically Bias Utility Weights from a Discrete Choice Experiment

    Dec 1, 2016, 00:00

  • ERRATUM

    Dec 1, 2016, 00:00

  • Arbitration Board Setting Reimbursement Amounts for Pharmaceutical Innovations in Germany When Price Negations between Payers and Manufacturers Fail- An Empirical Analysis of 5 Years’ Experience

    Dec 1, 2016, 00:00

  • Using Patient-Reported Outcomes for Economic Evaluation- Getting the Timing Right

    Dec 1, 2016, 00:00

  • Node-Splitting Generalized Linear Mixed Models for Evaluation of Inconsistency in Network Meta-Analysis

    Dec 1, 2016, 00:00

  • Improvements in Productivity at Paid Work and Within the Household, and Increased Participation in Daily Activities Over 52 Weeks of Certolizumab Pegol Treatment of Rheumatoid Arthritis- Results of A Belgian Observational Non-Interventional ...

    Nov 1, 2016, 00:00

  • Cost-Utility analysis of Insulin Degludec vs. Insulin Glargine U100 Treatment in Patients with Diabetes Mellitus type 1 and 2 in Serbia

    Nov 1, 2016, 00:00

  • Drug Utilisation of Braf Inhibitors for Melanoma in Ireland

    Nov 1, 2016, 00:00

  • Barriers To Intravitreal Injection Therapy Adherence In Dme Patients In Australia

    Nov 1, 2016, 00:00

  • Cost Avoidance Of Pharmacist Running Pediatrics Total Parenteral Nutrition Services At Ministry Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • Intravenous Fluids for Children- Cost and Threshold Analysis to Inform the National Institute for Health and Care Excellence (NICE) Clinical Guideline Recommendation

    Nov 1, 2016, 00:00

  • Caesarean Section In Xindu County of Chengdu, China- Trend And Its Correlates From 2008 to 2014

    Nov 1, 2016, 00:00

  • Clinical and Economic Benefits of a Community Pharmacy Vaccination Strategy

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life of Users of Primary Care in Brazil

    Nov 1, 2016, 00:00

  • Polypharmacy and Medication Adherence in Elderly Patients with Diabetes in Pafos General Hospital, Cyprus

    Nov 1, 2016, 00:00

  • The Current Status And Influential Factors of Insulin Pen Needle Reuse In T2D Patients From China

    Nov 1, 2016, 00:00

  • The Effect of Reducing Cost-Sharing for Children on Utilization of Inpatient Services- Evidence From Japan

    Nov 1, 2016, 00:00

  • The Prevalence of Nosocomial Infections in Karaganda (Kazakhstan) During 2011-2015

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of The Incorporation of A Computerized Temperature Management System In The Treatment of Therapeutic Hypothermia In Greece

    Nov 1, 2016, 00:00

  • Real World Treatment Patterns in Metastatic and/or Unresectable Gastric Cancer Patients in Brazil

    Nov 1, 2016, 00:00

  • The Comparisons of Biologics with Methotrexate for Treating Rheumatoid Arthritis Patients in Taiwan- The use of Cost-Utility Analysis and Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Comorbidity of Depression And Type 2 Diabetes- A Retrospective Japanese Claims Database Analysis

    Nov 1, 2016, 00:00

  • Cost-Outcome Analysis of Different Intravenous Iron Sucrose Preparations in Hemodialysis Patients

    Nov 1, 2016, 00:00

  • The Social Cost of Major Depression

    Nov 1, 2016, 00:00

  • Programme Budgeting Marginal Analysis for the Real World- The ‘Prudent Pbma’

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Panobinostat – Bortezomib and Dexamethasone, As 3rd Or 4th Line of Treatment in Patients with Relapsed/Refractory Multiple Myeloma in Greece

    Nov 1, 2016, 00:00

  • Generating Consistent and Reliable Evidence on Survival Estimates for Health Technology Assessment in Oncology and Haematology

    Nov 1, 2016, 00:00

  • Cost Burden of Crohn's Disease and Ulcerative Colitis in the United States

    Nov 1, 2016, 00:00

  • Clinical and Economic Outcomes of Pharmacist-Provided Home-Based Medication Review in the Elderly- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Effectiveness and Safety of Vemurafenib as Monotherapy in Unresectable or Metastatic Melanoma from an Academic Database- Real World Data to Strengthen Evidence for Payer

    Nov 1, 2016, 00:00

  • Making Pragmatic Trials Work

    Nov 1, 2016, 00:00

  • Improvements in Health-Related Quality of Life Associated with Increased Control of Postprandial Glucose Levels in Diabetes

    Nov 1, 2016, 00:00

  • Prescribing Behaviour And Drug Use In Pakistan

    Nov 1, 2016, 00:00

  • Do Pharmaceutical Cost Control Policies Effective In Reducing Pharmaceutical Expenditure And Volume? A Systematic Review

    Nov 1, 2016, 00:00

  • Evaluation of the Effect of Pharmaceutical Care Interventions on the Mean Daily Dose of Oral Antidiabetes Drugs in a Nigerian Tertiary Hospital

    Nov 1, 2016, 00:00

  • Burden Of Comorbidities In Hcv And Hiv/Hcv Patients. Real world evidence from italian administrative databases

    Nov 1, 2016, 00:00

  • Ankylosing Spondylitis is Associated with Significant Increases in Healthcare Resource Utilization And Costs in A German Real World Setting

    Nov 1, 2016, 00:00

  • Soft Modelling Of Health-Related Quality Of Life Specific To Hiv In Relation To Anxiety, Depression, Personality Traits And Precariousness

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Ibrutinib For Waldenström Macroglobulinemia In Italy

    Nov 1, 2016, 00:00

  • Adoption of Managed Entry Agreements in Established and Emerging Markets

    Nov 1, 2016, 00:00

  • EQ-5D Utility Value Sets for Sri Lanka- A Case For Economic Evaluations in South Asia

    Nov 1, 2016, 00:00

  • Clinical and Comparative Effectiveness of Telemonitoring Intervention Versus Usual Care For Type 2 Diabetes Mellitus- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Closed-System Transfer Device for Preparation of Antineoplastic Drugs in a Malaysian Public Hospital- Is it Truly Cost Saving?

    Nov 1, 2016, 00:00

  • A Study of Prescription Pattern of Non Steroidal Anii-Inflammatory Drugs in a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Psychometric Properties of The Chinese Version of Problem Areas In Diabetes Scale (Sg-Paid-C) Among High-Risk Polypharmacy Patients With Uncontrolled Type 2 Diabetes In Singapore

    Nov 1, 2016, 00:00

  • Exploring Interest in The Use of A Complementary Therapy Among Individuals With Copd

    Nov 1, 2016, 00:00

  • Economic Consequences Of The Choices In Injectable Anticoagulants In France

    Nov 1, 2016, 00:00

  • Qualitative Research Approaches In Rare Diseases- Acid Sphingomyelinase Deficiency (ASMD) Symptoms and Impact as Reported by Patients and Caregivers

    Nov 1, 2016, 00:00

  • Current Status of Endoscopic Submucosal Dissection Treatment for Gastric Adenoma in Korea- Based on National Claims Database

    Nov 1, 2016, 00:00

  • Missed Opportunities in The Netherlands- The Negligence of Non-Statistical Uncertainty in Ced Policy

    Nov 1, 2016, 00:00

  • Proton Pump Inhibitors and Major Adverse Cardiovascular Outcomes- A Systematic Review

    Nov 1, 2016, 00:00

  • Adherence To Vancomycin Therapeutic Guidelines At Ministry Of Health Hospital In Saudi Arabia

    Nov 1, 2016, 00:00

  • Comparison of Health Care Utilization And Cost Depending on The Severity of Asthma in Adults- Analysis of The Korean National Health Insurance Claims Database

    Nov 1, 2016, 00:00

  • Disease Related Knowledge, Medication Adherence And Glycaemic Control Among Patients With Type 2 Diabetes Mellitus In Pakistan

    Nov 1, 2016, 00:00

  • Utilisation of Antiretrovirals in the Slovak Republic - A 10-Year Retrospective Study

    Nov 1, 2016, 00:00

  • Self-Care Behavior And Medication Use Of Buddhist Monks With Diabetes Mellitus In Phasi Charoen, Bangkok

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Overactive Bladder Treatment with Mirabegron in Patients in South Korea

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Treatment of Children with Severe Uncontrolled Asthma with Omalizumab In Russia

    Nov 1, 2016, 00:00

  • The Application of Population Models to Improve Access to Medical Innovations and Population Health – A Systematic Review

    Nov 1, 2016, 00:00

  • The Predirtion of The Brca1/2-Related Ovarian Cancer Morbility In Russia

    Nov 1, 2016, 00:00

  • Tocilizumab Monotherapy As The First Line of Biological Treatment In Rheumatoid Arthritis- Budget Impact Analyses From The Perspective of Brazilian Public Healthcare System (SUS)

    Nov 1, 2016, 00:00

  • Oral Versus Intravenous Iron Treatment in Patients with Inflammatory Bowel Disease and Iron Deficiency and/or Anemia in Germany

    Nov 1, 2016, 00:00

  • A Systematic Review of Utility Derivation Methods- Time Trade off in Comparison to EQ-5D

    Nov 1, 2016, 00:00

  • International Pediatric Hospital Patient Outcomes

    Nov 1, 2016, 00:00

  • Non-Invasive Vagus Nerve Stimulation As A Treatment For Headache Patients with Multi-Morbidity- Real World Experience In English Primary Care

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life in Systemic Sclerosis- Feasibility and Construct Validity of Eq-5d

    Nov 1, 2016, 00:00

  • Impaired Quality Of Life After Chikungunya Virus Infection- A 12-Months Follow-Up Study Of Its Chronic Inflammatory Rheumatism In La Virginia, Risaralda, Colombia

    Nov 1, 2016, 00:00

  • Influencing Factors On Knowledge, Attitude And Behaviour Towards Antibiotic Usage Among Adults In Ho Chi Minh City, Viet Nam

    Nov 1, 2016, 00:00

  • Hepatitis B Vaccination in Dialysis Patients. Is it Really Protective?

    Nov 1, 2016, 00:00

  • Cost Per Responder Analysis of Sucrofferric Oxhydroxide Versus Sevelamer Carbonate in Patients on Hemodialysis in Europe

    Nov 1, 2016, 00:00

  • Economic Analyses of Diagnostic Tests for HCC Surveillan A Systematic Review

    Nov 1, 2016, 00:00

  • Romanian Claw-Back Taxation- From A Financial Solution to A Challenge for Patients Access to Drugs

    Nov 1, 2016, 00:00

  • Concentration Analysis Of Hungarian Health Care Providers Between 2006-2015

    Nov 1, 2016, 00:00

  • Integration of HIV Aids Program Intervention into Universal Health Coverage (UHC) - Lesson Learned from Indonesia

    Nov 1, 2016, 00:00

  • Relevance And Economic Consequences Of Medicine Waste In Vienna- Analysis Of A Household Garbage Sample

    Nov 1, 2016, 00:00

  • The Dynamic Evolution of External Price Referencing Implementation in Various Countries

    Nov 1, 2016, 00:00

  • The Influence of Glycemic Control in the Quality of Life of Type 2 Diabetes Mellitus Patients in Greece-the Hypo2 Study

    Nov 1, 2016, 00:00

  • Understanding the Relationship Between Effectiveness and Outcome Indicators in Health Care

    Nov 1, 2016, 00:00

  • A Proposed Model for the Study of the Longitudinal Behavior of Prevalence Rates

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of Dabigatran, Enoxaparin, and Usual Care for Venous Thromboprophylaxis after Hip or Knee Replacement Surgery in Thailand

    Nov 1, 2016, 00:00

  • Innovative Medical Device Design Significantly Reduces Surgeon Intra-Procedural Stress Levels (Ipsl)

    Nov 1, 2016, 00:00

  • Cost of Type 2 Diabetes in Urban Indian Population

    Nov 1, 2016, 00:00

  • Satisfaction Level of Patients, Physicians, and Private Primary Healthcare Center Managers with Chronic Disease Management Program in Indonesia

    Nov 1, 2016, 00:00

  • Effect of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Statins on Sepsis-Related Outcomes

    Nov 1, 2016, 00:00

  • Can Acute Phase Clinical Outcomes Predict Health-Related Quality of Life After Stroke?

    Nov 1, 2016, 00:00

  • The Clinical And Pharmacoeconomic Challenges For Securing Reimbursement And Access To Cdx In The Eu

    Nov 1, 2016, 00:00

  • Pro Instruments for Musculoskeletal Disorders used in Studies Published Since 2005- Which Diseases have had the most Tools Developed?

    Nov 1, 2016, 00:00

  • Weakness of Registration Bioequivalent Drugs

    Nov 1, 2016, 00:00

  • Considerations in Meta-Analytic Network Design- The Case of Platinum Doublet Chemotherapies in Advanced Non-Small Cell Lung Cancer (Advnsclc)

    Nov 1, 2016, 00:00

  • Using Advanced Modeling To Identify The Factor Structure of The Improved Health Activities Questionnaire

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Assessment Of Pegaspargase Versus Asparaginase in Acute Lymphocytic Leukemia

    Nov 1, 2016, 00:00

  • A Systematic Review- Economic Burden Of Needlestick Injuries On Healthcare Workers

    Nov 1, 2016, 00:00

  • Severe ulcerative collitis in children and adolescents in poland – it’s time to catch up with Europe. Budget impact analysis (Bia) for biosimilar infliximab

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Improved Influenza Vaccination Coverage in Adults Aged 60 Years and Older in Beijing, China

    Nov 1, 2016, 00:00

  • Trends in The Utilization, Spending, and Prices For Smoking Cessation and Nicotine Replacement Products In US Medicaid Programs- 1991–2015

    Nov 1, 2016, 00:00

  • Benefits of An Automatic Tool For Glucose Pattern Detection

    Nov 1, 2016, 00:00

  • An a Priori Decision Criteria Elicitation Method for Treatment Decision-Making in Elderly Colorectal Cancer Patients

    Nov 1, 2016, 00:00

  • Cost Comparison in the Management of Adult Patients with Advanced Soft Tissue Sarcoma Previously Treated in Spain- Pazopanib vs. Trabectedina

    Nov 1, 2016, 00:00

  • General Practitioners Awareness On Medicines Cost And Financing In Bosnia And Herzegovina

    Nov 1, 2016, 00:00

  • Drug Utilization Evaluation of Antibiotics in General Medicine Department of a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Nivolumab Monotherapy for the Treatment of Advanced Melanoma Patients in the United Kingdom

    Nov 1, 2016, 00:00

  • Impact of Trial Design on Price Discounts after Early Benefit Assessment (AMNOG) in Germany

    Nov 1, 2016, 00:00

  • Factors Associated with Glycemic Control and Diabetes-Related Costs in Patients with Diabetes in the United Arab Emirates- Results From A Retrospective Large Claims Data Analysis

    Nov 1, 2016, 00:00

  • Cost-Utility of Unicompartmental Compared To Total Knee Replacements- An Analysis Based on Matched Routinely-Collected Data From The United Kingdom

    Nov 1, 2016, 00:00

  • Perceptions of Thalassemia Patients' on Thalassemia and Its Treatment- A Qualitative Exploration

    Nov 1, 2016, 00:00

  • Cost Efectivness of Darbepoetin Alfa Versus Epoetin Alfa In The Management of Anemic Patients With Chronic Kidney Disease-Health Insurance Perspective

    Nov 1, 2016, 00:00

  • Life Expectancy, Quality-Adjusted Life Years, and Total Lifetime Costs for Australian People with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Everolimus for Patients with Advanced Neuroendocrine Tumors of the Gastrointestinal (GI) or Lung Origin -A Canadian Societal Health Care System Perspective

    Nov 1, 2016, 00:00

  • Key Aspects in the Modelling of Dengue Transmission- Results from a Focused Literature Review

    Nov 1, 2016, 00:00

  • Three-Monthly Long-Acting Antipsychotic Therapy Results in A Better Treatment Continuity Compared to A One-Monthly or Bi-Weekly Treatment In Schizophrenia

    Nov 1, 2016, 00:00

  • Can Pharmaceutical Care Intervention Improve Lipid Profile in Type 2 Diabetes Patients; A Prospective Intervention Study in a Tertiary Hospital in Nigeria

    Nov 1, 2016, 00:00

  • How Does Pricing and Access of Innovative Oncology Agents in China Compare with Other Asian Markets?

    Nov 1, 2016, 00:00

  • Do Nutrition Interventions Require a Different Approach to Economic Evaluation?

    Nov 1, 2016, 00:00

  • The Cost Effectiveness of Tumour Necrosis Factor-α Inhibitors For Ankylosing Spondylitis And Non-Radiographic Axial Spondyloarthritis

    Nov 1, 2016, 00:00

  • Assessing Statin-Associated Myopathy using Administrative Data from a German Health Insurance Fund- Results of a Pilot Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared With Non-Surgical Treatment of Morbid Obesity In Poland

    Nov 1, 2016, 00:00

  • The Trend of High Dose Insulin Initiated Among Diabetes Patients in UK

    Nov 1, 2016, 00:00

  • The Stool Antigen Test For Detection of Helicobacter Pylori For Diagnose H.Pylori Infection And Assessment of Eradication Therapy

    Nov 1, 2016, 00:00

  • The Situate Detection System - A Cost-Effective Approach to Preventing Retained Surgical Sponges

    Nov 1, 2016, 00:00

  • Fabrication of Anti-Vitiligo Ointment Containing Psoralia Corylifolia- Invitro and Invivo Characterization

    Nov 1, 2016, 00:00

  • Burden of Disease and Healthcare Costs of Patients Treated with Antiglaucoma Drugs

    Nov 1, 2016, 00:00

  • Using Geographical Information Systems To Describe Quality Of Life As A Function Of Distance In Cancer Patients

    Nov 1, 2016, 00:00

  • The Use of Consensus Techniques to Inform Health Technology Appraisals

    Nov 1, 2016, 00:00

  • Recommended vs Reimbursed vs Actually used Chemiotherapeutics in Pancreatic Adenocarcinoma in Poland

    Nov 1, 2016, 00:00

  • Differences in Perception of Health-Related Quality of Life Associates to Socioeconomic, Cultural and Housing Factors- Multilevel Analysis

    Nov 1, 2016, 00:00

  • Why Should We Focus on A Structured Model of Secure Digital Exchanges To Incorporate New Documents In Electronic Patient Records?

    Nov 1, 2016, 00:00

  • Asthma in Fran Analysis of 2015 National Health and Wellness Survey Data

    Nov 1, 2016, 00:00

  • A Barriers to and Facilitators of the use of HTA Reports by Policymakers in Kazakhstan

    Nov 1, 2016, 00:00

  • Budget Impact Model of Secukinumab In The Treatment of Ankylosing Spondylitis (AS) And With Psoriatic Arthritis (PSA) In Italy

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pembrolizumab vs. Docetaxel for Treatment of Previously Treated PD-l1 Positive Advanced NSCLC Patients

    Nov 1, 2016, 00:00

  • The Clinical And Pharmacoeconomic Value of Febuxostat For The Treatment of Persistent Hyperuricaemia- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Sacubitril/Valsartan in Chronic Heart Failure with Reduced Ejection Fraction in Spain

    Nov 1, 2016, 00:00

  • Impact Of Us Health Exchanges (Hix) On The Pharmaceutical Industry

    Nov 1, 2016, 00:00

  • Comparision Of Perception Towrds Generic Medicines Between Final Year Pharmacy And Medical Students In Southeast Yemen

    Nov 1, 2016, 00:00

  • Adherence To Treatment And Modifiable Risk Factors In Acute Coronary Syndrome (Acs) Patients Registered In The Pgrx Real World Datasets

    Nov 1, 2016, 00:00

  • Multiple Myeloma and Health-Related Quality of Life from EQ-5D and EORTC- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Standardisation and Compatibility Between HTA Networks- what Impacts on Quality?

    Nov 1, 2016, 00:00

  • Development of A Global Model For The Economic Evaluation of A Biomarker For The Treatment of Uncontrolled Moderate To Severe Asthma

    Nov 1, 2016, 00:00

  • Economic Burden Of Diseases In Fran Analysing The Trends From 2012 To 2014, Using The French Health Insurance Database (Sniiram)

    Nov 1, 2016, 00:00

  • Cost of Ebola Virus Disease Diagnosis Using Rapid Point-Of-Care Diagnostics in Sierra Leone

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Dulaglutide Versus Liraglutide in Patients with Type 2 Diabetes Mellitus in Taiwan

    Nov 1, 2016, 00:00

  • Comparison of German, French and Polish Utility Weights for The Eortc Utility Instrument QLU-C10D

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Empagliflozin in Patients with T2DM and High CV Risk in Canada

    Nov 1, 2016, 00:00

  • Medication Cost Of Acute Myeloid Leukemia- A Descriptive Study

    Nov 1, 2016, 00:00

  • Olokizumab Treatment of both Western and Asian Patients with Rheumatoid Arthritis who have Failed Anti-Tnf Treatment Results in Sustained Improvements in Patient-Reported Outcomes

    Nov 1, 2016, 00:00

  • A Review of Studies of Health-Related Quality of Life Performed in Chinese-Speaking Ischemic Heart Disease Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Sq® Hdm Slit-Tablet For House Dust Mite Respiratory Allergic Disease In Czech Republic

    Nov 1, 2016, 00:00

  • Real World Tolerability And Effectiveness of Exenatide Once-Weekly Compared To Basal Insulin Among Elderly Patients with Type 2 Diabetes (T2D)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Mechanical Thrombectomy Using Stent-Retriever After Intravenous T-PA Compared with Intravenous T-PA Alone in The Treatment of Acute Ischemic Stroke Due to Large Vessel Occlusion in Spain

    Nov 1, 2016, 00:00

  • Measurement Properties of The EQ-5D-5l Compared To The EQ-5D-3L In Psoriasis Patients

    Nov 1, 2016, 00:00

  • Hepatitis C Treatment with First-Generation Protease Inhibitors in A Real-World Cohort- Risk-Benefit Profile and Costs of the Therapy

    Nov 1, 2016, 00:00

  • Assessment of Knowledge and Perception Regarding Breast Cancer Among Patients Attending Gynecological Department of Tertiary Care Hospital in Quetta Pakistan

    Nov 1, 2016, 00:00

  • Assessing the Broader Economic Consequences of Hpv Prevention in Indonesia Using a Government Perspective Fiscal Analytic Method

    Nov 1, 2016, 00:00

  • Cancer Prevention- Knowledge And Attitudes Among Healthcare Professionals

    Nov 1, 2016, 00:00

  • Incidence and Risk Factors of Glucocorticoid-Induced Diabetes Mellitus in Lymphoma Patients Treated with Glucocorticoid-Containing Chemotherapy

    Nov 1, 2016, 00:00

  • Effect of Clinical Pharmacist in Patient Safety-A Prospective Interventional Study

    Nov 1, 2016, 00:00

  • Higher Weight, Higher Burden- Outcomes Of Adults In Japan With Type 2 Diabetes

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of The 13-Valent Pneumococcal Conjugate Vaccine In Adults In Portugal

    Nov 1, 2016, 00:00

  • The Cost Of Illness of Ultra-Rare Cryopyrin Associated Periodic Syndromes (CAPS) In Italy- Preliminary Results From The Radicea Project

    Nov 1, 2016, 00:00

  • Management of Soft Tissue Sarcoma in France - A Retrospective Analysis of The French Clinical Biological Sarcoma Database (CONTICANET)

    Nov 1, 2016, 00:00

  • Comparison Of Biosimilar Guideline And Real Consumption Among Italian Regions

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Olaparib Use in Patients Brca – Mutated Psroc in Greece

    Nov 1, 2016, 00:00

  • A Review of Assessments of The Quality of Pharmacoeconomic Evaluations in China

    Nov 1, 2016, 00:00

  • The Health Economics Analysis of Unqualified Venous Blood Samples In The Chinese Tertiary Referral Hospital

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilization (HCRU) in Relapsed/Refractory Multiple Myeloma (RRMM)- Comparison of EU and US Cohorts in the Preamble Study

    Nov 1, 2016, 00:00

  • Nine Tests For Assesing Validity Of A Discrete-Choice Experiment

    Nov 1, 2016, 00:00
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69 (current)
  • 70
  • »